Azithromycin add-on therapy in high-risk postendoscopic sinus surgery patients failing corticosteroid irrigations: A clinical practice audit.
CONCLUSION: A significant subgroup of high-risk patients showing disease recurrence after ESS despite topical corticosteroid therapy may respond to the addition of AZI as part of their therapy. These findings suggest that topical steroid-unresponsive CRS may represent a distinct entity and that alternate anti-inflammatory agents may be required for optimal management.
PMID: 24598145 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - Category: ENT & OMF Authors: Maniakas A, Desrosiers M Tags: Am J Rhinol Allergy Source Type: research
More News: Allergy | Allergy & Immunology | Alpha-1 Antitrypsin Deficiency | Azithromycin | Corticosteroid Therapy | ENT & OMF | Lower Endoscopy | Staphylococcus Aureus | Statistics | Study | Zithromax